Effect of CD133-positive stem cells in repeated recurrence of hepatocellular carcinoma after liver transplantation: a case report.

Takeo Toshima, Tomoharu Yoshizumi, Hideaki Uchiyama, Toru Ikegami, Yuji Soejima, Tetsuo Ikeda, Hirofumi Kawanaka, Yo Ichi Yamashita, Masaru Morita, Eiji Oki, Koshi Mimori, Keishi Sugimachi, Hiroshi Saeki, Masayuki Watanabe, Ken Shirabe, Yoshihiko Maehara

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Liver transplantation (LT) is currently one of the best available strategies for treating multiple hepatocellular carcinoma (HCC) and decompensated liver cirrhosis. However, patients often undergo HCC recurrence after LT, with most HCC recurrences detected at 1-2 years. CD133 was the first identified member of the prominin family of pentaspan membrane proteins and is a marker of hepatic stem cells. Here, we report a unique case of seven repeated recurrences of HCC in the lungs after LT, with all HCC recurrences resected curatively by a thoracoscopic approach. Pathological examination revealed moderately differentiated HCC identical to that in the original histology of the liver tumor. Interestingly, no CD133 immunoreactivity was observed in cancerous lesions of the primary HCC and the 1st to 2nd recurrences, as indicated by immunohistochemistry. However, CD133 was strongly stained in the cancerous lesions from the 3rd to 7th recurrences. The patient survived and had no recurrence after 9 years of the initial living donor LT. In conclusion, we investigated an evocative case of seven repeated recurrences of HCC in the lungs to elucidate the significance of circulating CD133-positive hepatic stem cells. This case illustrates the need for further research to clarify the mutual effect of CD133-positive hepatic stem cells for the development of new therapeutic strategies.

Original languageEnglish
Pages (from-to)383-388
Number of pages6
JournalUnknown Journal
Volume104
Issue number10
Publication statusPublished - Jan 1 2013

Fingerprint

transplantation
Liver Transplantation
Hepatocellular Carcinoma
Stem Cells
stem
Recurrence
lesion
Hepatocytes
histology
tumor
Hydroxyethyl Starch Derivatives
membrane
Lung
protein
effect
Living Donors
Liver Cirrhosis
Histology
Membrane Proteins
Immunohistochemistry

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Effect of CD133-positive stem cells in repeated recurrence of hepatocellular carcinoma after liver transplantation : a case report. / Toshima, Takeo; Yoshizumi, Tomoharu; Uchiyama, Hideaki; Ikegami, Toru; Soejima, Yuji; Ikeda, Tetsuo; Kawanaka, Hirofumi; Yamashita, Yo Ichi; Morita, Masaru; Oki, Eiji; Mimori, Koshi; Sugimachi, Keishi; Saeki, Hiroshi; Watanabe, Masayuki; Shirabe, Ken; Maehara, Yoshihiko.

In: Unknown Journal, Vol. 104, No. 10, 01.01.2013, p. 383-388.

Research output: Contribution to journalArticle

Toshima, T, Yoshizumi, T, Uchiyama, H, Ikegami, T, Soejima, Y, Ikeda, T, Kawanaka, H, Yamashita, YI, Morita, M, Oki, E, Mimori, K, Sugimachi, K, Saeki, H, Watanabe, M, Shirabe, K & Maehara, Y 2013, 'Effect of CD133-positive stem cells in repeated recurrence of hepatocellular carcinoma after liver transplantation: a case report.', Unknown Journal, vol. 104, no. 10, pp. 383-388.
Toshima, Takeo ; Yoshizumi, Tomoharu ; Uchiyama, Hideaki ; Ikegami, Toru ; Soejima, Yuji ; Ikeda, Tetsuo ; Kawanaka, Hirofumi ; Yamashita, Yo Ichi ; Morita, Masaru ; Oki, Eiji ; Mimori, Koshi ; Sugimachi, Keishi ; Saeki, Hiroshi ; Watanabe, Masayuki ; Shirabe, Ken ; Maehara, Yoshihiko. / Effect of CD133-positive stem cells in repeated recurrence of hepatocellular carcinoma after liver transplantation : a case report. In: Unknown Journal. 2013 ; Vol. 104, No. 10. pp. 383-388.
@article{384927fe8c964cfeb7aeca82ca560ba7,
title = "Effect of CD133-positive stem cells in repeated recurrence of hepatocellular carcinoma after liver transplantation: a case report.",
abstract = "Liver transplantation (LT) is currently one of the best available strategies for treating multiple hepatocellular carcinoma (HCC) and decompensated liver cirrhosis. However, patients often undergo HCC recurrence after LT, with most HCC recurrences detected at 1-2 years. CD133 was the first identified member of the prominin family of pentaspan membrane proteins and is a marker of hepatic stem cells. Here, we report a unique case of seven repeated recurrences of HCC in the lungs after LT, with all HCC recurrences resected curatively by a thoracoscopic approach. Pathological examination revealed moderately differentiated HCC identical to that in the original histology of the liver tumor. Interestingly, no CD133 immunoreactivity was observed in cancerous lesions of the primary HCC and the 1st to 2nd recurrences, as indicated by immunohistochemistry. However, CD133 was strongly stained in the cancerous lesions from the 3rd to 7th recurrences. The patient survived and had no recurrence after 9 years of the initial living donor LT. In conclusion, we investigated an evocative case of seven repeated recurrences of HCC in the lungs to elucidate the significance of circulating CD133-positive hepatic stem cells. This case illustrates the need for further research to clarify the mutual effect of CD133-positive hepatic stem cells for the development of new therapeutic strategies.",
author = "Takeo Toshima and Tomoharu Yoshizumi and Hideaki Uchiyama and Toru Ikegami and Yuji Soejima and Tetsuo Ikeda and Hirofumi Kawanaka and Yamashita, {Yo Ichi} and Masaru Morita and Eiji Oki and Koshi Mimori and Keishi Sugimachi and Hiroshi Saeki and Masayuki Watanabe and Ken Shirabe and Yoshihiko Maehara",
year = "2013",
month = "1",
day = "1",
language = "English",
volume = "104",
pages = "383--388",
journal = "Quaternary International",
issn = "1040-6182",
publisher = "Elsevier Limited",
number = "10",

}

TY - JOUR

T1 - Effect of CD133-positive stem cells in repeated recurrence of hepatocellular carcinoma after liver transplantation

T2 - a case report.

AU - Toshima, Takeo

AU - Yoshizumi, Tomoharu

AU - Uchiyama, Hideaki

AU - Ikegami, Toru

AU - Soejima, Yuji

AU - Ikeda, Tetsuo

AU - Kawanaka, Hirofumi

AU - Yamashita, Yo Ichi

AU - Morita, Masaru

AU - Oki, Eiji

AU - Mimori, Koshi

AU - Sugimachi, Keishi

AU - Saeki, Hiroshi

AU - Watanabe, Masayuki

AU - Shirabe, Ken

AU - Maehara, Yoshihiko

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Liver transplantation (LT) is currently one of the best available strategies for treating multiple hepatocellular carcinoma (HCC) and decompensated liver cirrhosis. However, patients often undergo HCC recurrence after LT, with most HCC recurrences detected at 1-2 years. CD133 was the first identified member of the prominin family of pentaspan membrane proteins and is a marker of hepatic stem cells. Here, we report a unique case of seven repeated recurrences of HCC in the lungs after LT, with all HCC recurrences resected curatively by a thoracoscopic approach. Pathological examination revealed moderately differentiated HCC identical to that in the original histology of the liver tumor. Interestingly, no CD133 immunoreactivity was observed in cancerous lesions of the primary HCC and the 1st to 2nd recurrences, as indicated by immunohistochemistry. However, CD133 was strongly stained in the cancerous lesions from the 3rd to 7th recurrences. The patient survived and had no recurrence after 9 years of the initial living donor LT. In conclusion, we investigated an evocative case of seven repeated recurrences of HCC in the lungs to elucidate the significance of circulating CD133-positive hepatic stem cells. This case illustrates the need for further research to clarify the mutual effect of CD133-positive hepatic stem cells for the development of new therapeutic strategies.

AB - Liver transplantation (LT) is currently one of the best available strategies for treating multiple hepatocellular carcinoma (HCC) and decompensated liver cirrhosis. However, patients often undergo HCC recurrence after LT, with most HCC recurrences detected at 1-2 years. CD133 was the first identified member of the prominin family of pentaspan membrane proteins and is a marker of hepatic stem cells. Here, we report a unique case of seven repeated recurrences of HCC in the lungs after LT, with all HCC recurrences resected curatively by a thoracoscopic approach. Pathological examination revealed moderately differentiated HCC identical to that in the original histology of the liver tumor. Interestingly, no CD133 immunoreactivity was observed in cancerous lesions of the primary HCC and the 1st to 2nd recurrences, as indicated by immunohistochemistry. However, CD133 was strongly stained in the cancerous lesions from the 3rd to 7th recurrences. The patient survived and had no recurrence after 9 years of the initial living donor LT. In conclusion, we investigated an evocative case of seven repeated recurrences of HCC in the lungs to elucidate the significance of circulating CD133-positive hepatic stem cells. This case illustrates the need for further research to clarify the mutual effect of CD133-positive hepatic stem cells for the development of new therapeutic strategies.

UR - http://www.scopus.com/inward/record.url?scp=84897575228&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897575228&partnerID=8YFLogxK

M3 - Article

C2 - 24511670

AN - SCOPUS:84897575228

VL - 104

SP - 383

EP - 388

JO - Quaternary International

JF - Quaternary International

SN - 1040-6182

IS - 10

ER -